AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Enhancement Of Crispr Genome Editing

Technology Benefits
Enhances binding of the Cas9-guide RNA complex to target DNA
Technology Application
Genome editing Site-directed modification of target DNA
Detailed Technology Description
None
Application No.
9982277
Others

Publication

The homologous recombination machinery modulates the formation of RNA–DNA hybrids and associated chromosome instability 


Additional Technologies by these Inventors


Tech ID/UC Case

23337/2013-155-0


Related Cases

2013-155-0

*Abstract

When researching genome instability can arise as a result of mistakes occurring during inappropriate hybridization of RNA to its DNA template, UC Berkeley researchers discovered that use of a Rad51 protein could increase the efficiency of Cas9-mediated target DNA modification.  The Rad51p helped to join stretches of nucleic acids together to repair breaks in DNA by enhancing the binding of Cas9 polypeptide and guide RNA complex to the target DNA.


*IP Issue Date
May 29, 2018
*Principal Investigator

Name: Douglas Koshland

Department:


Name: Lamia Wahba

Department:

Country/Region
USA

For more information, please click Here
Mobile Device